These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 30734484)
1. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis. Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of DNMT3a expression by RNAi and its effect on NF-κBs expression of thymic epithelial cells. Meng FJ; Guo F; Sun ZN; Wang SJ; Yang CR; Wang CY; Zhang WC; Gao ZY; Ji LL; Feng FK; Guan ZY; Wang GS Immunol Lett; 2021 Sep; 237():17-26. PubMed ID: 34192561 [TBL] [Abstract][Full Text] [Related]
3. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes. Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A Front Immunol; 2020; 11():664. PubMed ID: 32373124 [TBL] [Abstract][Full Text] [Related]
4. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune regulator expression in thymomas with or without autoimmune disease. Liu Y; Zhang H; Zhang P; Meng F; Chen Y; Wang Y; Yao Y; Qi B Immunol Lett; 2014 Sep; 161(1):50-6. PubMed ID: 24768600 [TBL] [Abstract][Full Text] [Related]
6. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers. Pascuzzi RM; Sermas A; Phillips LH; Johns TR Neurology; 1986 Mar; 36(3):423-7. PubMed ID: 3951715 [TBL] [Abstract][Full Text] [Related]
7. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes. Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429 [TBL] [Abstract][Full Text] [Related]
8. Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma. Geuder KI; Marx A; Witzemann V; Schalke B; Kirchner T; Müller-Hermelink HK Lab Invest; 1992 Apr; 66(4):452-8. PubMed ID: 1583885 [TBL] [Abstract][Full Text] [Related]
9. Multiomics data reveals the influences of myasthenia gravis on thymoma and its precision treatment. Ruan X; Lu X; Gao J; Jiang L; Zhu Y; Zhou Y; Meng J; Yan H; Yan F; Wang F J Cell Physiol; 2021 Feb; 236(2):1214-1227. PubMed ID: 32700803 [TBL] [Abstract][Full Text] [Related]
10. Genetic characterization of thymoma. Yu L; Ke J; Du X; Yu Z; Gao D Sci Rep; 2019 Feb; 9(1):2369. PubMed ID: 30787364 [TBL] [Abstract][Full Text] [Related]
11. Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit from a thymoma associated with myasthenia [correction of myastenia] gravis. Gattenlöhner S; Brabletz T; Schultz A; Marx A; Müller-Hermelink HK; Kirchner T Thymus; 1994; 23(2):103-13. PubMed ID: 7725386 [TBL] [Abstract][Full Text] [Related]
12. Altered expression of miR-125a-5p in thymoma-associated myasthenia gravis and its down-regulation of foxp3 expression in Jurkat cells. Li J; Qiu D; Chen Z; Du W; Liu J; Mo X Immunol Lett; 2016 Apr; 172():47-55. PubMed ID: 26875774 [TBL] [Abstract][Full Text] [Related]
13. Alteration in gene expression profiles of thymoma: Genetic differences and potential novel targets. Meng FJ; Wang S; Zhang J; Yan YJ; Wang CY; Yang CR; Guan ZY; Wang CL Thorac Cancer; 2019 May; 10(5):1129-1135. PubMed ID: 30932350 [TBL] [Abstract][Full Text] [Related]
14. Aberrant decrease of microRNA19b regulates TSLP expression and contributes to Th17 cells development in myasthenia gravis related thymomas. Wang Z; Chen Y; Xu S; Yang Y; Wei D; Wang W; Huang X J Neuroimmunol; 2015 Nov; 288():34-9. PubMed ID: 26531692 [TBL] [Abstract][Full Text] [Related]
15. LncRNA and mRNA expression associated with myasthenia gravis in patients with thymoma. Ke J; Du X; Cui J; Yu L; Li H Thorac Cancer; 2022 Jan; 13(1):15-23. PubMed ID: 34773374 [TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients. Lee MC; Hsiao TH; Chuang HN; Lee LW; Chi PL; Tsai HM; Mao CL; Hsu CP Lung Cancer; 2020 Jan; 139():157-164. PubMed ID: 31809976 [TBL] [Abstract][Full Text] [Related]
17. Genetic association of Ctla-4 to myasthenia gravis with thymoma. Huang D; Liu L; Norén K; Xia SQ; Trifunovic J; Pirskanen R; Lefvert AK J Neuroimmunol; 1998 Aug; 88(1-2):192-8. PubMed ID: 9688341 [TBL] [Abstract][Full Text] [Related]
18. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4 Wang T; Wang B; Fan X; Cai Y; Li L; Fu S Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105 [TBL] [Abstract][Full Text] [Related]
19. Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis. Wilisch A; Gutsche S; Hoffacker V; Schultz A; Tzartos S; Nix W; Schalke B; Schneider C; Müller-Hermelink HK; Marx A Neurology; 1999 Apr; 52(7):1460-6. PubMed ID: 10227635 [TBL] [Abstract][Full Text] [Related]